Compounds > 2,3-dibenzylbutane-1,4-diol
Page last updated: 2024-09-03

2,3-dibenzylbutane-1,4-diol and fluorouracil

2,3-dibenzylbutane-1,4-diol has been researched along with fluorouracil in 1 studies

Compound Research Comparison

Studies
(2,3-dibenzylbutane-1,4-diol)		Trials
(2,3-dibenzylbutane-1,4-diol)		Recent Studies (post-2010)
(2,3-dibenzylbutane-1,4-diol)		Studies
(fluorouracil)		Trials
(fluorouracil)		Recent Studies (post-2010) (fluorouracil)
80045,5629,30714,663

Protein Interaction Comparison

ProteinTaxonomy2,3-dibenzylbutane-1,4-diol (IC50)fluorouracil (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.32
Thymidylate synthaseMus musculus (house mouse)1.58
AromataseHomo sapiens (human)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuoka, K; Hirano, T; Hosaka, K; Matsumoto, Y; Mitsuhashi, H; Naito, T; Oka, K1

Other Studies

1 other study(ies) available for 2,3-dibenzylbutane-1,4-diol and fluorouracil

ArticleYear
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1.
    Cancer investigation, 1990, Volume: 8, Issue:6

    Topics: 4-Butyrolactone; Adenosine Triphosphatases; Animals; Benzyl Compounds; Breast Neoplasms; Butylene Glycols; Cell Division; Cell Line; Dogs; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney Cortex; Lethal Dose 50; Lignans; Ouabain

1990